{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T22:26:56Z","timestamp":1791757616546,"version":"4.3.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Nutr Rep"],"DOI":"10.1007\/s13668-025-00650-3","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T03:19:27Z","timestamp":1743995967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Role of Adiposity and Anthropometrics on Disease Progression in Autosomal Dominant Polycystic Kidney Disease: A Narrative Review"],"prefix":"10.1007","volume":"14","author":[{"given":"Baris","family":"Afsar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rengin Elsurer","family":"Afsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasar","family":"Caliskan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista L.","family":"Lentine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"issue":"10174","key":"650_CR1","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/s0140-6736(18)32782-x","volume":"393","author":"E Cornec-Le Gall","year":"2019","unstructured":"Cornec-Le Gall E, Alam A, Perrone RD. Autosomal dominant polycystic kidney disease. Lancet. 2019;393(10174):919\u201335. https:\/\/doi.org\/10.1016\/s0140-6736(18)32782-x.","journal-title":"Lancet"},{"issue":"25","key":"650_CR2","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","volume":"367","author":"VE Torres","year":"2012","unstructured":"Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2012;367(25):2407\u201318. https:\/\/doi.org\/10.1056\/NEJMoa1205511.","journal-title":"N Engl J Med"},{"issue":"20","key":"650_CR3","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","volume":"377","author":"VE Torres","year":"2017","unstructured":"Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Perrone RD, Koch G, et al. Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease. N Engl J Med. 2017;377(20):1930\u201342. https:\/\/doi.org\/10.1056\/NEJMoa1710030.","journal-title":"N Engl J Med"},{"issue":"8","key":"650_CR4","doi-asserted-by":"publisher","first-page":"F726","DOI":"10.1152\/ajprenal.00551.2015","volume":"310","author":"KR Kipp","year":"2016","unstructured":"Kipp KR, Rezaei M, Lin L, Dewey EC, Weimbs T. A mild reduction of food intake slows disease progression in an orthologous mouse model of polycystic kidney disease. Am J Physiol Renal Physiol. 2016;310(8):F726\u201331. https:\/\/doi.org\/10.1152\/ajprenal.00551.2015.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"650_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/kidneydial2010013","volume":"2","author":"C Steele","year":"2022","unstructured":"Steele C, Nowak K. Obesity, Weight Loss, Lifestyle Interventions, and Autosomal Dominant Polycystic Kidney Disease. Kidney Dial. 2022;2(1):106\u201322. https:\/\/doi.org\/10.3390\/kidneydial2010013.","journal-title":"Kidney Dial"},{"issue":"5","key":"650_CR6","doi-asserted-by":"publisher","first-page":"664","DOI":"10.2215\/cjn.0000000000000326","volume":"19","author":"FT Chebib","year":"2024","unstructured":"Chebib FT, Nowak KL, Chonchol MB, Bing K, Ghanem A, Rahbari-Oskoui FF, et al. Polycystic Kidney Disease Diet: What is Known and What is Safe. Clin J Am Soc Nephrol. 2024;19(5):664\u201382. https:\/\/doi.org\/10.2215\/cjn.0000000000000326.","journal-title":"Clin J Am Soc Nephrol"},{"key":"650_CR7","doi-asserted-by":"publisher","unstructured":"Martin-Hadma\u0219 RM, Martin \u0218 A, Romon\u021bi A, M\u0103rginean CO. The Effect of Dietary Intake and Nutritional Status on Anthropometric Development and Systemic Inflammation: An Observational Study. Int J Environ Res Public Health. 2021;18(11). https:\/\/doi.org\/10.3390\/ijerph18115635","DOI":"10.3390\/ijerph18115635"},{"issue":"4","key":"650_CR8","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1093\/advances\/nmaa006","volume":"11","author":"M Dinu","year":"2020","unstructured":"Dinu M, Pagliai G, Angelino D, Rosi A, Dall\u2019Asta M, Bresciani L, et al. Effects of Popular Diets on Anthropometric and Cardiometabolic Parameters: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials. Adv Nutr. 2020;11(4):815\u201333. https:\/\/doi.org\/10.1093\/advances\/nmaa006.","journal-title":"Adv Nutr"},{"issue":"1","key":"650_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.clnu.2019.02.003","volume":"39","author":"L Jiang","year":"2020","unstructured":"Jiang L, Audouze K, Romero Herrera JA, \u00c4ngquist LH, Kj\u00e6rulff SK, Izarzugaza JMG, et al. Conflicting associations between dietary patterns and changes of anthropometric traits across subgroups of middle-aged women and men. Clin Nutr. 2020;39(1):265\u201375. https:\/\/doi.org\/10.1016\/j.clnu.2019.02.003.","journal-title":"Clin Nutr"},{"issue":"10","key":"650_CR10","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1016\/j.ekir.2023.07.017","volume":"8","author":"PS Sagar","year":"2023","unstructured":"Sagar PS, Rangan GK. Cardiovascular Manifestations and Management in ADPKD. Kidney Int Rep. 2023;8(10):1924\u201340. https:\/\/doi.org\/10.1016\/j.ekir.2023.07.017.","journal-title":"Kidney Int Rep"},{"issue":"6","key":"650_CR11","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/ki.2011.411","volume":"81","author":"VE Torres","year":"2012","unstructured":"Torres VE, Chapman AB, Perrone RD, Bae KT, Abebe KZ, Bost JE, et al. Analysis of baseline parameters in the HALT polycystic kidney disease trials. Kidney Int. 2012;81(6):577\u201385. https:\/\/doi.org\/10.1038\/ki.2011.411.","journal-title":"Kidney Int"},{"issue":"2","key":"650_CR12","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1681\/asn.2017070819","volume":"29","author":"KL Nowak","year":"2018","unstructured":"Nowak KL, You Z, Gitomer B, Brosnahan G, Torres VE, Chapman AB, et al. Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol. 2018;29(2):571\u20138. https:\/\/doi.org\/10.1681\/asn.2017070819.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"650_CR13","doi-asserted-by":"publisher","first-page":"908","DOI":"10.2215\/cjn.16871020","volume":"16","author":"KL Nowak","year":"2021","unstructured":"Nowak KL, Steele C, Gitomer B, Wang W, Ouyang J, Chonchol MB. Overweight and Obesity and Progression of ADPKD. Clin J Am Soc Nephrol. 2021;16(6):908\u201315. https:\/\/doi.org\/10.2215\/cjn.16871020.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"650_CR14","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.xkme.2021.03.004","volume":"3","author":"KL Nowak","year":"2021","unstructured":"Nowak KL, Murray K, You Z, Gitomer B, Brosnahan G, Abebe KZ, et al. Pain and Obesity in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis of the Halt Progression of Polycystic Kidney Disease (HALT-PKD) Studies. Kidney Med. 2021;3(4):536-45.e1. https:\/\/doi.org\/10.1016\/j.xkme.2021.03.004.","journal-title":"Kidney Med"},{"issue":"4","key":"650_CR15","doi-asserted-by":"publisher","first-page":"824","DOI":"10.20960\/nh.03976","volume":"39","author":"O Persil-Ozkan","year":"2022","unstructured":"Persil-Ozkan O, Cebeci E, Sevim Y, Savas Y, Ozturk S, Tayfur M. The feasibility of anthropometric measurements for evaluation of abdominal obesity in patients with autosomal dominant polycystic kidney disease: A cross-sectional study. Nutr Hosp. 2022;39(4):824\u201334. https:\/\/doi.org\/10.20960\/nh.03976.","journal-title":"Nutr Hosp."},{"key":"650_CR16","doi-asserted-by":"publisher","unstructured":"Yamazaki M, Kawano H, Miyoshi M, Kimura T, Takahashi K, Muto S et al. Long-Term Effects of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Predictors of Treatment Response and Safety over 6 Years of Continuous Therapy. Int J Mol Sci. 2024;25(4). https:\/\/doi.org\/10.3390\/ijms25042088","DOI":"10.3390\/ijms25042088"},{"issue":"1","key":"650_CR17","doi-asserted-by":"publisher","first-page":"103697","DOI":"10.1016\/j.isci.2021.103697","volume":"25","author":"K Hopp","year":"2022","unstructured":"Hopp K, Catenacci VA, Dwivedi N, Kline TL, Wang W, You Z, et al. Weight loss and cystic disease progression in autosomal dominant polycystic kidney disease. iScience. 2022;25(1):103697. https:\/\/doi.org\/10.1016\/j.isci.2021.103697.","journal-title":"iScience"},{"key":"650_CR18","doi-asserted-by":"publisher","unstructured":"Dos Santos Dutra A, Rodrigues FG, da Rocha DR, Vendramini LC, de Matos ACC, Heilberg IP. Increased Body Fat and Organic Acid Anions Production Are Associated with Larger Kidney Size in ADPKD. Medicina (Kaunas). 2022;58(2). https:\/\/doi.org\/10.3390\/medicina58020152","DOI":"10.3390\/medicina58020152"},{"issue":"1","key":"650_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12882-016-0434-0","volume":"18","author":"H Ryu","year":"2017","unstructured":"Ryu H, Kim H, Park HC, Kim H, Cho EJ, Lee KB, et al. Total kidney and liver volume is a major risk factor for malnutrition in ambulatory patients with autosomal dominant polycystic kidney disease. BMC Nephrol. 2017;18(1):22.","journal-title":"BMC Nephrol"},{"issue":"4","key":"650_CR20","doi-asserted-by":"publisher","first-page":"e0214912","DOI":"10.1371\/journal.pone.0214912","volume":"14","author":"H Ryu","year":"2019","unstructured":"Ryu H, Park HC, Kim H, Heo J, Kang E, Hwang YH, et al. Bioelectrical impedance analysis as a nutritional assessment tool in Autosomal Dominant Polycystic Kidney Disease. PLoS ONE. 2019;14(4):e0214912.","journal-title":"PLoS ONE"},{"key":"650_CR21","doi-asserted-by":"publisher","unstructured":"Wu CH, Lai TS, Chen YM, Chen CM, Yang SC, Liang PC. Quantification of Abdominal Muscle Mass and Diagnosis of Sarcopenia with Cross-Sectional Imaging in Patients with Polycystic Kidney Disease: Correlation with Total Kidney Volume. Diagnostics (Basel). 2022;12(3). https:\/\/doi.org\/10.3390\/diagnostics12030755","DOI":"10.3390\/diagnostics12030755"},{"issue":"2","key":"650_CR22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3265\/Nefrologia.pre2011.Dec.10663","volume":"32","author":"M Pietrzak-Nowacka","year":"2012","unstructured":"Pietrzak-Nowacka M, Safranow K, Bi\u0144czak-Kuleta A, R\u00f3za\u0144ski J, Ciechanowski K, Ciechanowicz A. Association of C49620T ABCC8 polymorphism with anthropometric and metabolic parameters in patients with autosomal dominant polycystic kidney disease: a preliminary study. Nefrologia. 2012;32(2):153\u20139. https:\/\/doi.org\/10.3265\/Nefrologia.pre2011.Dec.10663.","journal-title":"Nefrologia"},{"key":"650_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.nutres.2021.07.006","volume":"93","author":"H Ryu","year":"2021","unstructured":"Ryu H, Yang YJ, Kang E, Ahn C, Yang SJ, Oh KH. Greater adherence to the dietary approaches to stop hypertension dietary pattern is associated with preserved muscle strength in patients with autosomal dominant polycystic kidney disease: a single-center cross-sectional study. Nutr Res. 2021;93:99\u2013110. https:\/\/doi.org\/10.1016\/j.nutres.2021.07.006.","journal-title":"Nutr Res"},{"issue":"4","key":"650_CR24","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1053\/j.jrn.2023.02.006","volume":"33","author":"J Lee","year":"2023","unstructured":"Lee J, Ryu H, Kim YC, Park HC, Ahn C, Lee KB, et al. Nutritional Status is Associated With Preserved Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease. J Ren Nutr. 2023;33(4):529\u201337. https:\/\/doi.org\/10.1053\/j.jrn.2023.02.006.","journal-title":"J Ren Nutr"},{"issue":"1","key":"650_CR25","doi-asserted-by":"publisher","first-page":"100755","DOI":"10.1016\/j.xkme.2023.100755","volume":"6","author":"D Oberdhan","year":"2024","unstructured":"Oberdhan D, Yarlas A, Bjorner JB, Krasa H. Patient-Reported Outcomes Measures, Polycystic Kidney Disease Burden, and Outcomes in Autosomal Dominant Polycystic Kidney Disease. Kidney Med. 2024;6(1):100755. https:\/\/doi.org\/10.1016\/j.xkme.2023.100755.","journal-title":"Kidney Med"},{"key":"650_CR26","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2024.02.014","author":"KL Nowak","year":"2024","unstructured":"Nowak KL, Moretti F, Bussola N, Steele CN, Gregory AV, Kline TL, et al. Visceral Adiposity and Progression of ADPKD: A Cohort Study of Patients From the TEMPO 3:4 Trial. Am J Kidney Dis. 2024. https:\/\/doi.org\/10.1053\/j.ajkd.2024.02.014.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"650_CR27","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1681\/asn.2015020132","volume":"27","author":"G Warner","year":"2016","unstructured":"Warner G, Hein KZ, Nin V, Edwards M, Chini CC, Hopp K, et al. Food Restriction Ameliorates the Development of Polycystic Kidney Disease. J Am Soc Nephrol. 2016;27(5):1437\u201347. https:\/\/doi.org\/10.1681\/asn.2015020132.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"650_CR28","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.cmet.2019.09.012","volume":"30","author":"JA Torres","year":"2019","unstructured":"Torres JA, Kruger SL, Broderick C, Amarlkhagva T, Agrawal S, Dodam JR, et al. Ketosis Ameliorates Renal Cyst Growth in Polycystic Kidney Disease. Cell Metab. 2019;30(6):1007-23.e5. https:\/\/doi.org\/10.1016\/j.cmet.2019.09.012.","journal-title":"Cell Metab"},{"issue":"4","key":"650_CR29","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2215\/cjn.13291019","volume":"15","author":"KL Nowak","year":"2020","unstructured":"Nowak KL, Hopp K. Metabolic Reprogramming in Autosomal Dominant Polycystic Kidney Disease: Evidence and Therapeutic Potential. Clin J Am Soc Nephrol. 2020;15(4):577\u201384. https:\/\/doi.org\/10.2215\/cjn.13291019.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4 Pt 2","key":"650_CR30","doi-asserted-by":"publisher","first-page":"F632","DOI":"10.1152\/ajprenal.1984.247.4.F632","volume":"247","author":"P Boer","year":"1984","unstructured":"Boer P. Estimated lean body mass as an index for normalization of body fluid volumes in humans. Am J Physiol. 1984;247(4 Pt 2):F632\u20136. https:\/\/doi.org\/10.1152\/ajprenal.1984.247.4.F632.","journal-title":"Am J Physiol"},{"issue":"1","key":"650_CR31","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1038\/s41598-023-30527-w","volume":"13","author":"SM Jeong","year":"2023","unstructured":"Jeong SM, Lee DH, Rezende LFM, Giovannucci EL. Different correlation of body mass index with body fatness and obesity-related biomarker according to age, sex and race-ethnicity. Sci Rep. 2023;13(1):3472. https:\/\/doi.org\/10.1038\/s41598-023-30527-w.","journal-title":"Sci Rep"},{"issue":"4","key":"650_CR32","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ekir.2019.01.003","volume":"4","author":"J Freise","year":"2019","unstructured":"Freise J, Tavakol M, Gao Y, Klein O, Lee BK, Freise C, et al. The Effect of Enlarged Kidneys on Calculated Body Mass Index Categorization in Transplant Recipients With ADPKD. Kidney Int Rep. 2019;4(4):606\u20139. https:\/\/doi.org\/10.1016\/j.ekir.2019.01.003.","journal-title":"Kidney Int Rep"},{"issue":"11","key":"650_CR33","doi-asserted-by":"publisher","first-page":"827","DOI":"10.7326\/m14-2525","volume":"163","author":"KR Sahakyan","year":"2015","unstructured":"Sahakyan KR, Somers VK, Rodriguez-Escudero JP, Hodge DO, Carter RE, Sochor O, et al. Normal-Weight Central Obesity: Implications for Total and Cardiovascular Mortality. Ann Intern Med. 2015;163(11):827\u201335. https:\/\/doi.org\/10.7326\/m14-2525.","journal-title":"Ann Intern Med"},{"issue":"6","key":"650_CR34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1159\/000260042","volume":"32","author":"M Pietrzak-Nowacka","year":"2009","unstructured":"Pietrzak-Nowacka M, Safranow K, Byra E, Bi\u0144czak-Kuleta A, Ciechanowicz A, Ciechanowski K. Metabolic syndrome components in patients with autosomal-dominant polycystic kidney disease. Kidney Blood Press Res. 2009;32(6):405\u201310. https:\/\/doi.org\/10.1159\/000260042.","journal-title":"Kidney Blood Press Res"},{"issue":"5","key":"650_CR35","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/med.0000000000000360","volume":"24","author":"T Lemos","year":"2017","unstructured":"Lemos T, Gallagher D. Current body composition measurement techniques. Curr Opin Endocrinol Diabetes Obes. 2017;24(5):310\u20134. https:\/\/doi.org\/10.1097\/med.0000000000000360.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"5","key":"650_CR36","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1139\/h08-075","volume":"33","author":"M Mourtzakis","year":"2008","unstructured":"Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008;33(5):997\u20131006. https:\/\/doi.org\/10.1139\/h08-075.","journal-title":"Appl Physiol Nutr Metab"},{"issue":"2","key":"650_CR37","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.clnu.2012.08.001","volume":"32","author":"UG Kyle","year":"2013","unstructured":"Kyle UG, Genton L, Pichard C. Low phase angle determined by bioelectrical impedance analysis is associated with malnutrition and nutritional risk at hospital admission. Clin Nutr. 2013;32(2):294\u20139. https:\/\/doi.org\/10.1016\/j.clnu.2012.08.001.","journal-title":"Clin Nutr"},{"issue":"6","key":"650_CR38","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1093\/ckj\/sfab162","volume":"15","author":"S Strubl","year":"2022","unstructured":"Strubl S, Oehm S, Torres JA, Grundmann F, Haratani J, Decker M, et al. Ketogenic dietary interventions in autosomal dominant polycystic kidney disease-a retrospective case series study: first insights into feasibility, safety and effects. Clin Kidney J. 2022;15(6):1079\u201392. https:\/\/doi.org\/10.1093\/ckj\/sfab162.","journal-title":"Clin Kidney J"},{"issue":"7","key":"650_CR39","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1093\/ndt\/gfac311","volume":"38","author":"S Oehm","year":"2023","unstructured":"Oehm S, Steinke K, Schmidt J, Arjune S, Todorova P, Heinrich Lindemann C, et al. RESET-PKD: a pilot trial on short-term ketogenic interventions in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2023;38(7):1623\u201335. https:\/\/doi.org\/10.1093\/ndt\/gfac311.","journal-title":"Nephrol Dial Transplant"},{"key":"650_CR40","doi-asserted-by":"crossref","unstructured":"Bruen DM, Kingaard JJ, Munits M, Paimanta CS, Torres JA, Saville J et al. Ren.Nu, a Dietary Program for Individuals with Autosomal-Dominant Polycystic Kidney Disease Implementing a Sustainable, Plant-Focused, Kidney-Safe, Ketogenic Approach with Avoidance of Renal Stressors. Kidney and Dialysis. 2022;2(2):183\u2013203","DOI":"10.3390\/kidneydial2020020"},{"issue":"11","key":"650_CR41","doi-asserted-by":"publisher","first-page":"101283","DOI":"10.1016\/j.xcrm.2023.101283","volume":"4","author":"S Cukoski","year":"2023","unstructured":"Cukoski S, Lindemann CH, Arjune S, Todorova P, Brecht T, K\u00fchn A, et al. Feasibility and impact of ketogenic dietary interventions in polycystic kidney disease: KETO-ADPKD-a randomized controlled trial. Cell Rep Med. 2023;4(11):101283. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101283.","journal-title":"Cell Rep Med"},{"issue":"5","key":"650_CR42","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2165\/11599410-000000000-00000","volume":"51","author":"MJ Brill","year":"2012","unstructured":"Brill MJ, Diepstraten J, van Rongen A, van Kralingen S, van den Anker JN, Knibbe CA. Impact of obesity on drug metabolism and elimination in adults and children. Clin Pharmacokinet. 2012;51(5):277\u2013304. https:\/\/doi.org\/10.2165\/11599410-000000000-00000.","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"650_CR43","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1055\/s-0035-1569341","volume":"124","author":"KC Lewandowski","year":"2016","unstructured":"Lewandowski KC, Brabant G. Potential Clinical Utility of Copeptin (C-terminal provasopressin) measurements in clinical medicine. Exp Clin Endocrinol Diabetes. 2016;124(3):173\u20137. https:\/\/doi.org\/10.1055\/s-0035-1569341.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1","key":"650_CR44","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.kint.2018.11.044","volume":"96","author":"RT Gansevoort","year":"2019","unstructured":"Gansevoort RT, van Gastel MDA, Chapman AB, Blais JD, Czerwiec FS, Higashihara E, et al. Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease. Kidney Int. 2019;96(1):159\u201369. https:\/\/doi.org\/10.1016\/j.kint.2018.11.044.","journal-title":"Kidney Int"},{"issue":"10","key":"650_CR45","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nrneph.2011.109","volume":"7","author":"JJ Grantham","year":"2011","unstructured":"Grantham JJ, Mulamalla S, Swenson-Fields KI. Why kidneys fail in autosomal dominant polycystic kidney disease. Nat Rev Nephrol. 2011;7(10):556\u201366. https:\/\/doi.org\/10.1038\/nrneph.2011.109.","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"650_CR46","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1111\/j.1523-1755.2005.00201.x","volume":"67","author":"AC Ong","year":"2005","unstructured":"Ong AC, Harris PC. Molecular pathogenesis of ADPKD: the polycystin complex gets complex. Kidney Int. 2005;67(4):1234\u201347. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00201.x.","journal-title":"Kidney Int"},{"issue":"3 Suppl 1","key":"650_CR47","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1053\/j.ajkd.2020.05.006","volume":"76","author":"TA Ikizler","year":"2020","unstructured":"Ikizler TA, Burrowes JD, Byham-Gray LD, Campbell KL, Carrero JJ, Chan W, et al. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update. Am J Kidney Dis. 2020;76(3 Suppl 1):S1-s107. https:\/\/doi.org\/10.1053\/j.ajkd.2020.05.006.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"650_CR48","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.kint.2020.04.053","volume":"98","author":"BJ Kramers","year":"2020","unstructured":"Kramers BJ, Koorevaar IW, Drenth JPH, de Fijter JW, Neto AG, Peters DJM, et al. Salt, but not protein intake, is associated with accelerated disease progression in autosomal dominant polycystic kidney disease. Kidney Int. 2020;98(4):989\u201398. https:\/\/doi.org\/10.1016\/j.kint.2020.04.053.","journal-title":"Kidney Int"},{"issue":"13","key":"650_CR49","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/nejm199403313301301","volume":"330","author":"S Klahr","year":"1994","unstructured":"Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med. 1994;330(13):877\u201384. https:\/\/doi.org\/10.1056\/nejm199403313301301.","journal-title":"N Engl J Med"},{"key":"650_CR50","doi-asserted-by":"publisher","unstructured":"Mwala NN, Borkent JW, van der Meij BS, de van der Schueren MAE. Challenges in identifying malnutrition in obesity; An overview of the state of the art and directions for future research. Nutr Res Rev. 2024:1\u201310. https:\/\/doi.org\/10.1017\/s095442242400012x","DOI":"10.1017\/s095442242400012x"},{"issue":"12","key":"650_CR51","doi-asserted-by":"publisher","first-page":"e0144526","DOI":"10.1371\/journal.pone.0144526","volume":"10","author":"H Kim","year":"2015","unstructured":"Kim H, Park HC, Ryu H, Kim K, Kim HS, Oh KH, et al. Clinical Correlates of Mass Effect in Autosomal Dominant Polycystic Kidney Disease. PLoS ONE. 2015;10(12):e0144526. https:\/\/doi.org\/10.1371\/journal.pone.0144526.","journal-title":"PLoS ONE"},{"issue":"1","key":"650_CR52","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/s13104-018-3472-9","volume":"11","author":"BE Grove","year":"2018","unstructured":"Grove BE, Schougaard LM, Hjollund NH, Ivarsen P. Self-rated health, quality of life and appetite as predictors of initiation of dialysis and mortality in patients with chronic kidney disease stages 4\u20135: a prospective cohort study. BMC Res Notes. 2018;11(1):371.","journal-title":"BMC Res Notes"},{"issue":"3","key":"650_CR53","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1053\/j.jrn.2022.10.006","volume":"33","author":"K Lambert","year":"2023","unstructured":"Lambert K, Miglioretto C, Javadpour A. Update on the Quality and Health Literacy Demand of Diet-Related Videos on YouTube for People With Polycystic Kidney Disease. J Ren Nutr. 2023;33(3):495\u20138. https:\/\/doi.org\/10.1053\/j.jrn.2022.10.006.","journal-title":"J Ren Nutr"}],"container-title":["Current Nutrition Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13668-025-00650-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13668-025-00650-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13668-025-00650-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T03:19:28Z","timestamp":1743995968000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13668-025-00650-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["650"],"URL":"https:\/\/doi.org\/10.1007\/s13668-025-00650-3","relation":{},"ISSN":["2161-3311"],"issn-type":[{"value":"2161-3311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"28 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"56"}}